Surrogate Endpoint ID'd for Prostate Cancer Trials.
Sign Up to like & getrecommendations! Published in 2017 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-nb2017-121
Abstract: Metastasis-free survival is a strong surrogate for overall survival for men with localized prostate cancer, a meta-analysis shows. The intermediate outcome measure could help accelerate the evaluation of novel adjuvant therapies in this patient population. read more here.
Keywords: prostate cancer; cancer trials; cancer; surrogate endpoint ... See more keywords